An Evaluation of Anticoagulant Therapy in Acute Myocardial Infarction

Baer S. Heine W. I. Krasnoff S. O. (1951). The mortality of acute myocardial infarction in private practice. Amer. J. med. Sci., 222, 500.

Bjerkelund C. J. (1953). The method of administering dicoumarol. Lancet, 6, 260.

Bresnick E. Selverstone L. A. Rapoport B. Cheskey K. Hultgren H. N. Sise H.S. (1950). Experiences with dicumarol in acute myocardial infarction. New England J. med., 243, 806.

Burton C. (1954). Anticoagulant therapy of recent cardiac infarction. Canad. med. Ass. J., 70, 404.

Cole D. R. Singian E. B. Katz L.N. (1954). The long-term prognosis following myocardial infarction and some factors which affect it. Circulation, 9, 321.

Doscher N. Poindexter C. A. (1950). Myocardial infarction without anticoagulant therapy. Amer. J. med., 8, 623.

Douglas A. S. Brown A. (1952). Effect of vitamin-K preparation on hypoprothrombinaemia induced by dicoumarol and tromexan. Brit. med. J., 1, 412.

Evans W. (1954). Anticoagulant therapy in coronary occlusion. Proc.R. Soc. med., 47, 318.

Feldman L. O'Connor W. R. Friedman I. A' Fischer J. W. (1952). Anticoagulant therapy in acute myocardial infarction. Amer. Heart J., 44, 112.

Feldman L. Schaefer G. L. Goldstein S. E. Forman I. M. (1954). Bishydroxy-coumarin (dicumarol) therapy in myocardial infarction; results of bishydroxycoumarin therapy as it is practised in a private hospital. Arch, intern, med., 94, 433.

Foley W. T. McDevitt E. Symons C. Wright I. S. (1955). Further experience with long-term anticoagulant therapy. Arch, intern, med., 95, 497.

Furman R. H. Ball C. O. T. Gale R. G. Billings F. T. Meneely G. R. (1953). An evaluation of anticoagulant therapy in myocardial infarction based on prognostic categories. Amer. J. med., 14, 681.

Garb S. (1955). Current status of anticoagulants in the treatment of myocardial infarction. Amer. J. med. Sci., 229, 534.

Gilchrist A. R. (1952). Coronary thrombosis and its response to treatment. Brit. med. J., 2, 351.

Gilchrist A. R. Tulloch J. A. (1954). Anticoagulants in coronary disease. Brit. med. J., 2, 720.

Gold H. (1954). How to evaluate a new drug. Amer. J. med., 17, 722.

Halpern M. M. Lemberg L. Belle M. Eichert H. (1954). The selective use of anticoagulants in acute myocardial infarction based on initial prognosis. Ann. intern, med., 41, 942.

Hellerstein H. K. Martin J. W. (1947). The incidence of thrombo-embolic lesions accompanying myocardial infarction. Amer. Heart J., 33, 443.

Holte N. C. (1951). Anticoagulants in the treatment of coronary thrombosis. Acta med. Scand., 140, 340.

Hunter R. B. (1954). La terapia anticoagulante nell' infarto del miocardio. Rec.Prog. med., 17, 332.

Hunter R. B. Walker W. (1954). The control of anticoagulant therapy in myocardial infarction. Brit. med. J., 2, 197.

Hunter R. B. (1955), personal communication.

Jordan R. A. Miller R. D. Edwards J. E. Parker R. L. (1952). Thrombo-embolism in acute and healed myocardial infarction. Circulation, 6, 1.

Kerwin A. J. (1953). Anticoagulants in treatment of cardiac infarction. Amer. Heart J., 46, 865.

Littman D. (1952). Prevention of thromboembolism in acute coronary artery disease. New England J., Med., 247, 205.

Loudon I. S. L. Pease J. C. Cooke A. M. (1953). Anticoagulants in myocardial infarction. Brit. med. J., 1, 911.

Macmillan R. L. Brown K. W. G. (1953). Haemorrhage in anticoagulant therapy. Canad. med. Ass. J., 69, 279.

Mainland D. (1953). The risk of fallacious conclusions from autopsy data on the incidence of diseases with applications to heart disease. Amer. Heart J., 45, 644.

Meakins J. C. Eakin W. W. (1932). Coronary thrombosis: A clinical and pathological study. Canad. med. Ass. J., 26, 18.

Miller R. D. Jordan R. A. Parker R. L. Edwards J. E. (1952). Thrombo-embolism in acute and in healed myocardial infarction; systemic and pulmonary arterial occlusion. Circulation, 6, 7.

Nichol E. S. Phillips W. C. Jenkins V. E. (1954). Anticoagulants in coronary heart disease. Med. Clin. N. America, 38, 399.

Papp C. Smith K. S. (1951). Prognosis and treatment of cardiac infarction. A survey of 200 patients. Brit. med. J., 1, 1471.

Peters H. R. Guyther J. R. Brambel C. E. (1946). Dicumarol in acute coronary thrombosis. J. Amer. med. Ass., 130, 398.

Rashkoff I. A. Schaefer L. E. Maida M. G. Levy H. (1952). Evaluation of dicumarol therapy in 287 cases of acute myocardial infarction. J. Mount Sinai Hosp., 18, 350.

Russek H. I. (1953). Therapeutic considerations and controversial issues in the modern management of acute myocardial infarction. Amer. J. med. Sci., 225, 589.

Russek H. I. Zohman B. L. (1952). Evaluation of anticoagulant therapy in treatment of acute myocardial infarction. Amer. Heart J., 43, 871.

Russek H. I. Zohman B. L. (1953). Anticoagulant therapy in acute myocardial infarction. Amer. J. Med., 14, 651.

Russek H. I. Zohman B. L. (1953). Anticoagulant therapy in acute myocardial infarction. Survey of specialists' opinions concerning indications, results and dangers. Amer. J. med. Sci., 225, 8.

Russek H. I. Zohman B. L. (1954). Selective versus routine use of anticoagulants in acute myocardial infarction. J. Amer. med. Ass., 156, 1130.

Russek H. I. Zohman B. L. Doerner A. A. Russek A. S. White L. G. (1952). Indications for bishydroxycoumarin (dicumarol) in acute myocardial infarction. Circulation, 5, 707.

Russek H.I. Zohman B. L. White C. La V. Doerner A. A. (1951). Indications for bishydroxycoumarin (dicumarol) in acute myocardial infarction. J. Amer. med. Ass., 145, 390.

Rytand D. A. (1951). Anticoagulants in coronary thrombosis with myocardial infarction. Arch. intern. Med., 88, 207.

Schilling F. J. (1950). Anticoagulants in myocardial infarction. J. Amer. med. Ass., 143, 785.

Schnür S. (1953). Mortality and other studies questioning the evidence for and value of routine anticoagulant therapy in acute myocardial infarction. Circulation, 7, 855.

Schnür S. (1954). The current dispute concerning anticoagulants in acute myocardial infarction. J. Amer. med. Ass., 156, 1127.

Smith F. J. Keyes J. W. Denham R. M. (1951). Myocardial infarction; study of acute phase in 20 patients. Amer. J. med. Sci., 221, 508.

Sougin-Mibashan R. Horwitz M. (1955). The uricosuric action of ethyl biscoumacetate. Lancet, 1, 1191.

Suzman M. M. Ruskin H. D. Goldberg B. (1955). An evaluation of the effect of continuous long-term anticoagulant therapy on the prognosis of myocardial infarction: A report of 82 cases. Circulation, 12, 338.

Tudhope G. R. Donald A. C. (1954). Late results of treatment in myocardial infarction; effect of short-term anticoagulant therapy on the mortality at one year. Lancet, 2, 465.

Tulloch J. A. Gilchrist A. R. (1950). Anticoagulants in treatment of coronary thrombosis. Brit. med. J., 2, 965.

Tulloch J. A. Gilchrist A. R. (1951). Tromexan in the treatment of coronary thrombosis. Amer. Heart J., 42, 864.

Tulloch J. A. Wright I. S. (1954). Long-term anticoagulant therapy: Further experiences. Circulation, 9, 823.

Wessler S. (1952). Studies in intravascular coagulation; coagulated changes in isolated venous segments. J. clin. Invest., 31, 1011.

Wessler S. (1953). Studies in intravascular coagulation. II. A comparison of the effects of dicumarol and heparin on clot formation in isolated venous segments. J. clin. Invest., 32, 650.

Wessler S. (1954). SPCA-induced thrombosis: Its pathogenesis and the effect of anticoagulants. J. clin. Invest., 33, 972.

Willis P. W. : quoted by Kark R. M. (1954). Oral anticoagulant therapy. Practitioner, 172, 90.

Wood P. (1955) personal communication.

Wright H. P. Kubik M. M. (1953). Recanalization of thrombosed arteries under anticoagulant therapy. Brit. med. J., 1, 1021.

Wright H.P. Kubik M. M. Hayden M. (1952). Influence of anticoagulant administration on rate of recanalization of experimentally thrombosed veins, Brit. J. Surg., 40, 163.

Wright I. S. (1953). The place of anticoagulants in coronary thrombosis. New York State J. Med., 53, 434.

Wright I. S. Marple C. D. Beck D. F. (1954). Myocardial Infarction: its clinical manifestations and treatment with anticoagulants. New York: Grune & Stratton.